Use of dexmedetomidine in treatment-refractory post-electroconvulsive therapy agitation.
The University of Adelaide, Adelaide, SA, Australia a1629805@student.adelaide.edu.au.
Danielle
D
Brydges
Cramond Clinic, The Queen Elizabeth Hospital, Woodville South, SA, Australia Discipline of Psychiatry, The University of Adelaide, Adelaide, SA, Australia.
Prashant
P
Tibrewal
ECT Services, The Queen Elizabeth Hospital, Woodville South, SA, Australia.
Sue
S
Waite
Discipline of Psychiatry, The University of Adelaide, Adelaide, SA, Australia Western Mental Health, The Queen Elizabeth Hospital, Woodville South, SA, Australia.
Rohan
R
Dhillon
D061218:Depressive Disorder, Treatment-Resistant / Q000628:therapy*; D020927:Dexmedetomidine / Q000627:therapeutic use*; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000209:etiology*; D016896:Treatment Outcome; D055815:Young Adult
D006993:Hypnotics and Sedatives; D020927:Dexmedetomidine